San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma
Venue: Sheraton San Diego Resort, San Diego, CA, United States
Official conference page for San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma. https://binaytara.org/projects/conferences/san-diego-hematologic-malignancies-symposium
About San Diego Hematologic Malignancies Symposium 2026: Advancing Evidence-Based Care in Leukemia, Lymphoma, and Myeloma


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Saturday, September 19th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
Session Chair: Vinod Pullarkat, MD
08:05 AM - 08:20 AM
Evolving Strategies in Acute Leukemias – Vinod Pullarkat, MD
08:25 AM - 09:05 AM
Case-Based Discussion
Session Chair: Kentson Lam
09:05 AM - 09:20 AM
Modern Management of MDS and MPNs
09:25 AM - 10:00 AM
Case-Based Discussion – Caitlin Costello, MD
Session Chair: Caitlin Costello, MD
10:45 AM - 11:00 AM
Emerging Therapies in Multiple Myeloma – Caitlin Costello, MD
11:05 AM - 11:15 AM
NDMM - role of transplant? PERSEUS vs CEPHEUS
11:15 AM - 11:25 AM
Early Relapse:CART vs. Bispecific
11:25 AM - 11:30 AM
Case-based Panel Discussion
Moderators:
Caitlin Costello, MD
01:00 PM - 01:15 PM
Current Approaches to High-Grade Lymphomas
01:20 PM - 01:35 PM
Double-hit DLBCL – Is intensified chemo (DA-EPOCH-R) still standard?
01:35 PM - 01:50 PM
Primary refractory DLBCL – CAR-T vs. Bispecifics – Autumn Jeong, MD
01:50 PM - 02:00 PM
Panel Discussion and Q&A
Panelists:
Autumn Jeong, MD
Session Chair: Bita Fakhri, MD, MPH
02:15 PM - 02:35 PM
How I Treat CLL: Practical Decision-Making – Michael Choi, MD
02:35 PM - 03:00 PM
CLL – Catherine Coombs, MD
03:00 PM - 03:15 PM
Optimizing Treatment Strategies in Low-Grade Lymphomas
03:20 PM - 03:50 PM
Low-grade lymphomas – Benjamin Heyman, MD
